Xiamen University
Records under this name other than the patents Xiamen University holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 112 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,748,127 | Truncated L1 Protein of Human Papillomavirus Type 6 now held by Xiamen Innovax Biotech Co., Ltd. In force · Medium confidence | In force | Medium confidence | |
| US 9,364,529 | Truncated L1 Protein of Human Papillomavirus Type 18 now held by Xiamen Innovax Biotech Co., Ltd. In force · Medium confidence | In force | Medium confidence | |
| US 9,428,555 | Truncated L1 Protein of Human Papillomavirus Type 16 now held by Xiamen Innovax Biotech Co., Ltd. In force · Medium confidence | In force | Medium confidence | |
| US 9,745,351 | Truncated L1 Protein of Human Papillomavirus Type 6 now held by Xiamen Innovax Biotech Co., Ltd. In force · High confidence | In force | High confidence | |
| US 9,943,586 | Truncated L1 Protein of Human Papillomavirus Type 11 now held by Xiamen Innovax Biotech Co., Ltd. In force · Medium confidence | In force | Medium confidence | |
| US 10,537,629 | Truncated L1 Protein of Human Papillomavirus Type 11 now held by Xiamen Innovax Biotech Co., Ltd. In force · High confidence | In force | High confidence | |
| US 9,222,090 | RNA Interference Target for Treating Aids In force · High confidence | In force | High confidence | |
| US 8,603,467 | Monoclonal Antibodies Binding to Avian Influenza Virus Subtype H5 Haemagglutinin and Uses Thereof In force · High confidence | In force | High confidence | |
| US 9,885,020 | ORF7 Deficient Varicella Virus, Vaccine Comprising the Virus and Use Thereof now held by Rutgers, the State University of New Jersey In force · High confidence | In force | High confidence | |
| US 9,533,035 | Truncated L1 Protein of Human Papillomavirus Type 11 now held by Xiamen Innovax Biotech Co., Ltd. In force · Medium confidence | In force | Medium confidence |